1. Comparación del mapa T1, T2 y VEC por RMC en pacientes con miocardiopatía inflamatoria post-COVID-19 vs. daño miocárdico de etiología autoinmune.
- Author
-
Martínez-Juárez, David, Gómez-Monterrosas, Omar, Zamora-Rosales, Francisco, Miró, Jordi, Cepeda-Ortiz, Daniel A., Gamero-Aguilar, Jaredh Z., Zamora-Medina, Jean, Mendoza-Aguilar, Rutilio, Sánchez-Guarneros, Karen H., and Rosales-Medina, Moses D.
- Abstract
Objective: Inflammatory cardiomyopathy is a disease associated with cardiac dysfunction and ventricular remodeling. Among the most recent diagnostic methods available, histologic characterization through cardiac magnetic resonance imaging (MRI) is used to identify inflammatory changes. Multiple studies have evaluated autoimmune mechanisms in myocardium damage following COVID-19, begging how feasible it is to differentiate and characterize lesions found in post-COVID-19 inflammatory cardiomyopathy. Method: Retrospective study comparing 29 MRI studies (12 diagnosed with post-COVID-19 inflammatory cardiomyopathy and 17 previously diagnosed with autoimmune cardiomyopathy, rheumatoid arthritis, scleroderma, or systemic lupus erythematosus), comparing the histologic characterization of T1, T2 mapping and extracellular volume (ECV) through cardiac MRI. Results: Post-COVID-19 inflammatory cardiomyopathy histologic characterization did not show significant differences compared to autoimmune myocardial lesions. T1 mapping 1109 ± 76 ms, T2 mapping 58 ± 6 ms, ECV 41 ± 9%. Myocardial lesions occurring from an autoimmune etiology showed: T1 mapping 1132 ± 122 ms, T2 mapping 61 ± 4 ms, and ECV 38 ± 8% (p > 0.05). Conclusion: T1-T2 mapping and ECV are similar among patients with post-COVID-19 inflammatory cardiomyopathy and myocardial damage secondary to autoimmune diseases, as there seem to exist similar pathologic mechanisms presenting in both groups, consistent with current literature regarding myocardial damage in SARS-CoV-2 infections. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF